Company / Operating Cash Flow per Share
Krystal Biotech, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$6.98
FY2025
5-year range
-$3.95 / $6.98
FY2021-FY2025
Trend
+59.6%
vs FY2024
Sector context
#17 of 212
Health Care
What the data says
Among 212 Health Care companies, Krystal Biotech, Inc. is in the top 8% for operating cash flow per share. Operating Cash Flow per Share has increased for 3 consecutive years, from $-3.95 in FY2022 to $6.98 in FY2025.
Based on SEC 10-K filings.
6.98 in FY2025. Top quartile in the Health Care sector.
Improved from $-3.45 to $6.98 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
+147.4% above sector average
Key checks
Key Insights
- Krystal Biotech, Inc.'s operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 59.6% year-over-year.
- Ranks #17 out of 212 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 5.66 (safe zone, above 2.9 threshold)
- Strong profit margin: 30.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.98 | +59.6% |
| FY2024 | $4.37 | +226.8% |
| FY2023 | -$3.45 | +12.6% |
| FY2022 | -$3.95 | -82.7% |
| FY2021 | -$2.16 | -55.6% |
| FY2020 | -$1.39 | -18.1% |
| FY2019 | -$1.18 | -39.4% |
| FY2018 | -$0.84 | -16.2% |
| FY2017 | -$0.73 | +51.4% |
| FY2016 | -$1.49 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026